ArticleMolecular cancer research : MCR2021

Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma.

Jeffim N Kuznetsoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.